false
Hamburger Menu
Catalog
The Lead Episode 36: One-Year Outcomes Following S ...
The Lead Episode 36: One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia
Description
William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests
Esseim Sharma, MD, of University Hospitals Cleveland, and
Paul C Zei, MD, PhD, FHRS, of Brigham and Women's Hospital to discuss One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia. Cardiac stereotactic body radiotherapy (SBRT) has emerged as a promising noninvasive treatment for refractory ventricular tachycardia (VT). The objective is to describe the safety and effectiveness of SBRT for VT in refractory to extensive ablation. For a select group of high-risk patients with VT refractory to standard therapy, SBRT is associated with a reduction of in VT and appropriate ICD therapies.
Learning Objectives
To learn about the experience of a single center on outcomes after SBRT for treatment of VT.
Article Authors and Podcast Contributors
Article Authors
Arkles J, Markman T, Trevillian R, Yegya-Raman N, Garg L, Nazarian S, Santangeli P, Garcia F, Callans D, Frankel DS, Supple G.
Podcast Contributors
William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital
Esseim Sharma, MD, of University Hospitals Cleveland
Paul C Zei, MD, PhD, FHRS, of Brigham and Women's Hospital
Disclosures
All relevant financial relationships have been mitigated.
Host Disclosure(s):
W. Sauer:
Honoraria/Speaking/Consulting Fee: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific; Research (Contracted Grants for PIs Named Investigators Only): Medtronic
Contributor Disclosure(s):
E. Sharma:
No relevant financial relationships with ineligible companies to disclose.
P. Zei:
Honoraria/Speaking/Consulting Fee: Varian Medical Systems, Biosense Webster, Inc., Abbott; Research (Contracted Grants for PIs Named Investigators Only): Biosense Webster, Inc.; Stocks (Publicly Traded): Affera, Inc.
Staff Disclosu
re(s)
(note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn:
No relevant financial relationships with ineligible companies to disclose.
S. Sailor:
No relevant financial relationships with ineligible companies to disclose.
S. Colbert:
No relevant financial relationships with ineligible companies to disclose.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
The Lead Episode 36: One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia Course List
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 42: Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 1: A Discussion of Left Bundle Branch Area Pacing Versus Biventricular Pacing as the Initial Implant Strategy for Cardiac Resynchronization Therapy
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 73: A Discussion of Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation
Multiple Credits
FREE
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 68: Ischemia-induced ventricular proarrhythmia and cardiovascular autonomic dysreflexia after cardioneuroablation
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 65: QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 63: Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial
Multiple Credits
FREE
(1)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Lead Episode 55: Dynamic Electrocardiogram changes are a novel risk marker for sudden Cardiac Death
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Core Concepts in Remote Monitoring 2023 Module 1: The Current State of Remote Monitoring in EP
Multiple Credits
$99.00 - $125.00
(7)
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English